These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

554 related items for PubMed ID: 7038299

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Skin test activity of an antigen fraction prepared from Mycobacterium leprae compared with standard lepromin and tuberculin PPD in leprosy patients.
    Reitan LJ, Touw-Langendijk EM, Closs O, Belehu A.
    Lepr Rev; 1984 Mar; 55(1):33-40. PubMed ID: 6369055
    [No Abstract] [Full Text] [Related]

  • 4. Comparative study of skin reactions in leprosy patients to M. leprae-lepromin and to antigens from cultivable saprophytic mycobacteria.
    Sharma RC, Singh R.
    Lepr India; 1978 Oct; 50(4):572-8. PubMed ID: 374876
    [No Abstract] [Full Text] [Related]

  • 5. Experiences with Mycobacterium leprae soluble antigens in a leprosy endemic population.
    Gupte MD, Anantharaman DS, Nagaraju B, Kannan S, Vallishayee RS.
    Lepr Rev; 1990 Jun; 61(2):132-44. PubMed ID: 2198413
    [Abstract] [Full Text] [Related]

  • 6. Immunological profiles of leprosy patients and healthy family contacts toward M. leprae antigens.
    Ilangumaran S, Ramanathan S, Shankernarayan N, Ramu G, Muthukkarauppan V.
    Int J Lepr Other Mycobact Dis; 1996 Mar; 64(1):6-14. PubMed ID: 8627115
    [Abstract] [Full Text] [Related]

  • 7. Studies on lepromin and soluble antigens of M.leprae: their classification standardization and use.
    Sengupta U.
    Indian J Lepr; 1991 Mar; 63(3-4):457-65. PubMed ID: 1804898
    [Abstract] [Full Text] [Related]

  • 8. Skin testing with mycobacterial reagents in leprosy.
    Stanford JL.
    Tubercle; 1984 Mar; 65(1):63-74. PubMed ID: 6203199
    [No Abstract] [Full Text] [Related]

  • 9. Quantitative relationship between anti-PGL-I-specific antibody levels and the lepromin reaction.
    David HL, Maroja M F, Cruaud P.
    Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):332-4. PubMed ID: 2071994
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Failure of Mycobacterium leprae soluble antigens to suppress delayed-type hypersensitivity reaction to tuberculin.
    Fine PE, Gruer PJ, Maine N, Ponnighaus JM, Rees RJ, Stanford JL.
    Clin Exp Immunol; 1989 Aug; 77(2):226-9. PubMed ID: 2673590
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Conversion of reactions to leprolin and lepromin in patients with lepromatous leprosy by the transfer factor.
    Han SH, Tsai LC, Hu SC, Loo ST.
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1980 Mar; 13(1):1-8. PubMed ID: 7004800
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The response of the patient with leprosy toward Mycobacterium leprae injected with lepromin. A histopathologic study four hours after injection.
    Saúl A.
    Int J Lepr Other Mycobact Dis; 1971 Mar; 39(2):300-7. PubMed ID: 4948077
    [No Abstract] [Full Text] [Related]

  • 17. Relative cross reactivity of habanin, lepromin and tuberculin in guinea pigs sensitized with homologous and heterologous mycobacteria.
    Singh NB, Srivastava A, Gupta HP, Kumar A, Chaturvedi VK.
    Indian J Lepr; 1988 Jul; 60(3):407-12. PubMed ID: 3143770
    [Abstract] [Full Text] [Related]

  • 18. Suppression of delayed hypersensitivity skin reactions to tuberculin by M. leprae antigens in patients with lepromatous and tuberculoid leprosy.
    Sengupta U, Sinha S, Ramu G, Lamb J, Ivanyi J.
    Clin Exp Immunol; 1987 Apr; 68(1):58-64. PubMed ID: 3308210
    [Abstract] [Full Text] [Related]

  • 19. Studies on the antigenic specificity of Mycobacterium leprae. II. Purification and immunological characterization of the soluble antigen in leprosy nodules.
    Abe M, Minagawa F, Yoshino Y, Okamura K.
    Int J Lepr Other Mycobact Dis; 1972 Apr; 40(2):107-17. PubMed ID: 4119113
    [No Abstract] [Full Text] [Related]

  • 20. [Lepromin scars in leprosy patients and persons without manifestations of the disease tested with human antigen and various concentrations of armadillo antigens (double-blind study)].
    Bechelli LM, Haddad N, Guimaraes Pagnano PM, Garrido Neves R, Melchior E, Carminatti Fregnan R.
    Acta Leprol; 1979 Apr; (76-77):173-9. PubMed ID: 121832
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.